I am an academic neuro-ophthalmologist with a major research interest in optic neuropathies, neurogenetics, and mitochondrial eye diseases. I hold a tenured Faculty position as Professor of Ophthalmology at the University of Cambridge, affiliated with the Cambridge Centre for Brain Repair and the MRC Mitochondrial Biology Unit. In addition to my academic roles, I have joint clinical appointments at Addenbrooke’s Hospital in Cambridge and Moorfields Eye Hospital in London as an Honorary Consultant Neuro-Ophthalmologist. My research group is exploring the disease mechanisms leading to progressive retinal ganglion cell loss in inherited optic neuropathies by using a combination of patient tissues, induced pluripotent stem cells, and animal models. I was awarded an NIHR Advanced Fellowship (2021-2026) to evaluate patient outcomes and therapies for this group of disorders. I am the Director of the Cambridge Clinical Vision Laboratory (CCVL) that was set up as a cross-cutting facility to support advanced therapeutics on the Cambridge Biomedical Campus.

Financial disclosure: Dr. Patrick Yu-Wai-Man has/had an affiliation (financial or otherwise) with a commercial organization:

• GenSight Biologics; Chiesi; Stoke Therapeutics; PYC Therapeutics - Consultant